Cytotoxicity refers to the ability of a substance to induce cell damage or death. In biology and medicine, cytotoxicity is often used to describe the toxic effects of various chemicals, drugs, or molecules on cells. When a substance exhibits cytotoxicity, it causes apoptosis (programmed cell death) or necrosis, ultimately impairing the function and viability of the affected cells. Substances that can cause cytotoxicity are known as cytotoxins. These can be manmade chemicals, natural substances made by living things (plants, animals, or bacteria), medications used to cure cancer (chemotherapy), or even immune system components that attack foreign or damaged cells. Cytotoxins can work in multiple ways, including rupturing cell membranes, interfering with intracellular functions like protein synthesis or DNA replication, or inducing an immune reaction directed against particular cells.
The term "cytotoxicity" describes the ability to be harmful or damaging to cells. When used in a biological context, cytotoxicity often refers to a substance's capacity to harm or kill live cells. These chemicals, known as cytotoxins, can either target certain cells or affect a wider range of cell types. A large number of biological processes and medical interventions depend on cytotoxicity. For instance, the immune system employs cytotoxic T cells to locate and eliminate aberrant or diseased cells within the body. These cytotoxic T cells are essential for the body's defense against germs and viruses, as well as for the identification and destruction of cancerous cells. Cytotoxicity is also a fundamental idea in the medical therapy of cancer. Chemotherapy medications target and kill cancer cells that divide quickly, which is how they treat different forms of cancer. These medications are made to minimize harm to the body's healthy cells while being cytotoxic to cancer cells. On the other hand, patients may also have adverse effects like fatigue, nausea, and hair loss due to the toxicity of these medications.
Cytotoxicity is an adverse reaction caused by the action of chemical substances (drugs) on the basic structure and/or physiological process of cells, such as cell membrane or cytoskeleton structure, cell metabolism, synthesis, degradation or release of cell components or products, ion regulation and cell division, leading to disorders in cell survival, proliferation and/or function. According to the mechanism of action, it can be divided into three types:
Cytotoxins are a class of potent substances that are capable of causing damage to cells and ultimately cell death. These toxic substances can be produced by a variety of organisms, such as bacteria, fungi, plants, and animals, and are known for their ability to disrupt cellular processes and cause tissue damage. A prominent example of a cytotoxin is botulinum toxin, produced by Clostridium botulinum. This neurotoxin is one of the most potent toxins known to man and can cause severe paralysis by interfering with nerve transmission at the neuromuscular junction. Botulinum toxin is widely used in cosmetic surgery to temporarily reduce the appearance of wrinkles by causing muscle paralysis. Another common cytotoxin is ricin, a highly toxic protein extracted from castor beans. Ricin works by inhibiting protein synthesis in cells, causing cell death and tissue damage. Due to its potency and relative ease of production, it is notorious for use as a biological weapon.
Cytotoxic drugs | Drugs that act directly on DNA | Alkylating agents | |
Metal platinum complexes | |||
Bleomycins | |||
DNA topoisomerase inhibitors | |||
Antimetabolites | Folic acid antagonists | ||
Pyrimidine antagonists | |||
Purine antagonists | |||
Multi-target antagonists | |||
Structural protein drugs | Drugs that inhibit tubulin polymerization | ||
Drugs that inhibit tubulin depolymerization | |||
Drugs that interfere with ribosome function | |||
Drugs that affect amino acid supply |
Table 1. Classification of cytotoxic agents.
Cytotoxins have also been investigated for potential therapeutic applications, particularly in cancer treatment. Some cytotoxins have been developed as chemotherapeutic agents that selectively target and kill cancer cells, providing a targeted approach to cancer treatment with fewer side effects on healthy tissue. These drugs work by targeting and destroying rapidly dividing cells in the body, including cancer cells. Once these drugs are ingested through skin contact or inhalation, low doses can cause toxicity to the reproductive, urinary, liver and kidney systems, such as carcinogenicity and teratogenicity.
Cytotoxic drugs are designed to interfere with the cell division process, ultimately leading to cell death. They are classified based on their mechanism of action, chemical structure, and specific targets within the cell. These drugs can be administered orally, intravenously, topically, or by injection, depending on the specific condition being treated.
BOC Sciences is a leading supplier of cytotoxic compounds, offering a comprehensive range of high-quality products for research, drug development, and more. We offer a wide range of cytotoxic compounds, including natural products, synthetic compounds, and specialty derivatives, all produced to the highest standards of purity and quality. Our catalog includes a wide range of potent compounds with different mechanisms of action, making them suitable for a wide range of research applications.
Catalog | Product Name | CAS Number | Price |
BADC-00798 | Actinomycin D | 50-76-0 | Inquiry |
BADC-00801 | Epirubicin | 56420-45-2 | Inquiry |
BADC-00036 | Triptolide | 38748-32-2 | Inquiry |
BADC-00328 | Topotecan | 123948-87-8 | Inquiry |
BADC-00034 | Taltobulin | 228266-40-8 | Inquiry |
BADC-00714 | Maytansinol | 57103-68-1 | Inquiry |
BADC-00796 | Sibiromycin | 12684-33-2 | Inquiry |
BADC-00188 | Auristatin E | 160800-57-7 | Inquiry |
BADC-00318 | MMAF | 745017-94-1 | Inquiry |
BADC-01397 | Chimmitecan | 185425-25-6 | Inquiry |
Cytotoxic drugs are a class of drugs that work by targeting and destroying rapidly dividing cells, such as cancer cells. These drugs are used to treat various types of cancer, autoimmune diseases, and other conditions where cell growth needs to be inhibited. There are several common cytotoxic drugs, each with its own mechanism of action and side effects.
Alkylating agents work by adding alkyl groups to the DNA of cancer cells, which prevents the cells from dividing and growing. Examples of alkylating agents include cyclophosphamide, temozolomide, and cisplatin. These drugs are commonly used to treat various types of cancer, such as breast cancer, ovarian cancer, and leukemia. Side effects of alkylating agents may include nausea, vomiting, hair loss, and increased risk of infection.
Antimetabolites interfere with the metabolic processes of cancer cells, causing cell death. These drugs mimic the structure of naturally occurring molecules (such as nucleotides or amino acids) within cells and disrupt their function. Common examples of antimetabolites include methotrexate, 5-fluorouracil, and gemcitabine. Antimetabolites are often used to treat solid tumors, such as colorectal cancer and pancreatic cancer. Side effects of antimetabolites may include diarrhea, mouth ulcers, and decreased blood cell counts.
Topoisomerase inhibitors work by interfering with enzymes responsible for unwinding and reeling up DNA strands during cell division. By inhibiting these enzymes, topoisomerase inhibitors prevent cancer cells from copying their DNA and dividing. Examples of topoisomerase inhibitors include etoposide, irinotecan, and doxorubicin. These drugs are commonly used to treat various types of cancer, such as lung cancer, lymphomas, and sarcomas. Side effects of topoisomerase inhibitors may include nausea, hair loss, and an increased risk of secondary cancers.
Mitotic inhibitors disrupt the process of mitosis, which is the division of a cell nucleus into two identical nuclei. By interfering with microtubules, a structure that helps cells divide, mitotic inhibitors prevent cancer cells from completing cell division and eventually induce cell death. Examples of mitotic inhibitors include paclitaxel, docetaxel, and vinblastine. Mitotic inhibitors are commonly used to treat breast, lung, and ovarian cancers. Side effects of mitotic inhibitors may include neuropathy, fatigue, and low blood cell counts.
Anthracyclines work by binding to DNA and interfering with its replication, as well as producing free radicals that damage the DNA of cancer cells. Examples of anthracyclines include doxorubicin, daunorubicin, and epirubicin. These drugs are commonly used to treat various types of cancer, such as breast cancer, leukemia, and lymphoma. Side effects of anthracyclines may include heart damage, nausea, and increased risk of infection.
Platinum compounds bind to and cross-link DNA, preventing it from replicating properly and causing cell death. Examples of platinum compounds include cisplatin, carboplatin, and oxaliplatin. These drugs are commonly used to treat ovarian cancer, testicular cancer, and lung cancer. Side effects of platinum compounds may include kidney damage, nerve damage, and hearing loss.
The clinical uses of cytotoxic drugs are wide and varied, playing a vital role in the treatment of various cancers, autoimmune diseases, and other diseases characterized by abnormal cell proliferation. Cytotoxic drugs, also known as chemotherapeutic drugs, work by targeting and destroying rapidly dividing cells, both cancerous and healthy cells. Although they have significant side effects due to their nonspecificity, their effectiveness in eliminating cancer cells and suppressing immune responses makes them indispensable drugs in modern medicine.
One of the main clinical uses of cytotoxic drugs is in the treatment of cancer. Cytotoxic drugs disrupt the cell cycle and inhibit DNA replication, leading to the death of rapidly dividing cancer cells. These drugs are often used in combination therapy regimens to target multiple stages of the cell cycle and reduce the likelihood of developing drug resistance. Different classes of cytotoxic drugs target specific mechanisms within the cell cycle. For example, antimetabolites such as methotrexate and 5-fluorouracil interfere with DNA synthesis by mimicking the structure of essential nucleotides. Alkylating agents such as cyclophosphamide and cisplatin cross-link DNA chains, preventing normal replication. On the other hand, microtubule inhibitors such as paclitaxel and vincristine disrupt the formation of the mitotic spindle, leading to cell death. In addition to their direct anticancer effects, cytotoxic drugs are used in adjuvant therapy to prevent cancer recurrence after surgery or radiation therapy. These drugs can target residual cancer cells that may have escaped primary treatment, reducing the risk of metastasis and improving overall survival. Adjuvant chemotherapy is commonly used in breast, colon, and lung cancers, among others.
In addition, cytotoxic drugs play a key role in the treatment of hematologic malignancies such as leukemia, lymphoma, and multiple myeloma. These cancers originate in hematopoietic tissues and typically involve abnormal proliferation of white blood cells. Chemotherapy regimens for these specific cancers target circulating and bone marrow-resident cancer cells with the goal of inducing remission and preventing relapse.
In addition to cancer treatment, cytotoxic drugs are used to treat autoimmune diseases. Autoimmune diseases are caused by an overactive immune response that targets healthy tissues and organs. Cytotoxic drugs suppress the immune system by targeting the rapidly dividing lymphocytes responsible for the autoimmune response. Drugs such as azathioprine and mycophenolate mofetil inhibit lymphocyte proliferation, thereby reducing inflammation and tissue damage in diseases such as rheumatoid arthritis, lupus, and multiple sclerosis.
In addition, cytotoxic drugs are used in organ transplantation to prevent transplant rejection. The transplanted organ is recognized as foreign by the recipient's immune system, which results in an immune response that can lead to organ failure. Immunosuppressive cytotoxic drugs such as tacrolimus and sirolimus are used to suppress the immune response and achieve a successful transplant. These drugs are often part of a lifelong maintenance regimen to ensure long-term survival of the transplanted organ.